⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

Official Title: Precision Promise Platform Trial for Metastatic Pancreatic Cancer

Study ID: NCT04229004

Study Description

Brief Summary: Precision Promise is a multi-center, seamless Phase 2/3 platform trial designed to evaluate multiple regimens in metastatic pancreatic cancer. Primary Objectives * To compare each investigational arm versus standard of care (SOC) for superiority in overall survival in first and/or second line metastatic ductal adenocarcinoma (metastatic pancreatic cancer) participants and determine which, if any, participants benefit from each investigational arm. Secondary Objectives * To determine short and long-term safety signals of each investigational arm in metastatic pancreatic cancer participants vs. SOC. * To determine progression-free survival (PFS) for each investigational arm vs. SOC. * To determine rates of overall response, CR, and PR; duration of overall response, CR or PR (whichever occurs first). * To determine rates of clinical benefit; duration of clinical benefit.

Detailed Description: Precision Promise is a multi-center, seamless Phase 2/3 platform trial designed to evaluate multiple regimens in metastatic pancreatic cancer. The goal of the platform is to find effective therapies for pancreatic cancer. The platform will test multiple investigational drugs and combinations compared to standard of care therapy in first and second line metastatic participants. Bayesian response-adaptive randomization will be used to assign participants to arms based on their performance in subtypes of the disease. The primary endpoint is overall survival.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla, California, United States

Cedars-Sinai Medical Center, Los Angeles, California, United States

University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

University of Florida College of Medicine, Gainesville, Florida, United States

Sylvester Comprehensive Cancer Center, Miami, Florida, United States

The University of Chicago Medical Center, Chicago, Illinois, United States

Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

University of Michigan - Rogel Cancer Center, Ann Arbor, Michigan, United States

Mayo Clinic Cancer Center (MCCC), Rochester, Minnesota, United States

Siteman Cancer Center - Washington University Medical Campus, Saint Louis, Missouri, United States

University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States

New York University Langone Medical Center - Perlmutter Cancer Center, New York, New York, United States

Evelyn H. Lauder Breast Center - Memorial Sloan Kettering Cancer Center, New York, New York, United States

Weill Cornell Physicians - Solid Tumor/Gastrointestinal Oncology, New York, New York, United States

University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States

University of Pennsylvania - Abramson Cancer Center, Philadelphia, Pennsylvania, United States

The University of Texas Southwestern Medical Center, Dallas, Texas, United States

Baylor College of Medicine, Houston, Texas, United States

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Huntsman Cancer Institute, Salt Lake City, Utah, United States

Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States

Virginia Mason Hospital & Seattle Medical Center, Seattle, Washington, United States

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: